Intellectual property claims may hinder using genomic tools for the betterment of public health, particularly for combating non-communicable diseases like type 2 diabetes, writes Anna George, an adjunct professor at Murdoch University in Australia and a Chatham House associate fellow, at the Guardian Professional.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.